Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
29 May 2024
Historique:
received: 19 07 2023
accepted: 18 03 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 28 5 2024
Statut: epublish

Résumé

Healthy lifestyles are inversely associated with the risk of noncommunicable diseases, which are leading causes of death. However, few studies have used longitudinal data to assess the impact of changing lifestyle behaviours on all-cause and cancer mortality. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, lifestyle profiles of 308,497 cancer-free adults (71% female) aged 35-70 years at recruitment across nine countries were assessed with baseline and follow-up questionnaires administered on average of 7 years apart. A healthy lifestyle index (HLI), assessed at two time points, combined information on smoking status, alcohol intake, body mass index, and physical activity, and ranged from 0 to 16 units. A change score was calculated as the difference between HLI at baseline and follow-up. Associations between HLI change and all-cause and cancer mortality were modelled with Cox regression, and the impact of changing HLI on accelerating mortality rate was estimated by rate advancement periods (RAP, in years). After the follow-up questionnaire, participants were followed for an average of 9.9 years, with 21,696 deaths (8407 cancer deaths) documented. Compared to participants whose HLIs remained stable (within one unit), improving HLI by more than one unit was inversely associated with all-cause and cancer mortality (hazard ratio [HR]: 0.84; 95% confidence interval [CI]: 0.81, 0.88; and HR: 0.87; 95% CI: 0.82, 0.92; respectively), while worsening HLI by more than one unit was associated with an increase in mortality (all-cause mortality HR: 1.26; 95% CI: 1.20, 1.33; cancer mortality HR: 1.19; 95% CI: 1.09, 1.29). Participants who worsened HLI by more than one advanced their risk of death by 1.62 (1.44, 1.96) years, while participants who improved HLI by the same amount delayed their risk of death by 1.19 (0.65, 2.32) years, compared to those with stable HLI. Making healthier lifestyle changes during adulthood was inversely associated with all-cause and cancer mortality and delayed risk of death. Conversely, making unhealthier lifestyle changes was positively associated with mortality and an accelerated risk of death.

Sections du résumé

BACKGROUND BACKGROUND
Healthy lifestyles are inversely associated with the risk of noncommunicable diseases, which are leading causes of death. However, few studies have used longitudinal data to assess the impact of changing lifestyle behaviours on all-cause and cancer mortality.
METHODS METHODS
Within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, lifestyle profiles of 308,497 cancer-free adults (71% female) aged 35-70 years at recruitment across nine countries were assessed with baseline and follow-up questionnaires administered on average of 7 years apart. A healthy lifestyle index (HLI), assessed at two time points, combined information on smoking status, alcohol intake, body mass index, and physical activity, and ranged from 0 to 16 units. A change score was calculated as the difference between HLI at baseline and follow-up. Associations between HLI change and all-cause and cancer mortality were modelled with Cox regression, and the impact of changing HLI on accelerating mortality rate was estimated by rate advancement periods (RAP, in years).
RESULTS RESULTS
After the follow-up questionnaire, participants were followed for an average of 9.9 years, with 21,696 deaths (8407 cancer deaths) documented. Compared to participants whose HLIs remained stable (within one unit), improving HLI by more than one unit was inversely associated with all-cause and cancer mortality (hazard ratio [HR]: 0.84; 95% confidence interval [CI]: 0.81, 0.88; and HR: 0.87; 95% CI: 0.82, 0.92; respectively), while worsening HLI by more than one unit was associated with an increase in mortality (all-cause mortality HR: 1.26; 95% CI: 1.20, 1.33; cancer mortality HR: 1.19; 95% CI: 1.09, 1.29). Participants who worsened HLI by more than one advanced their risk of death by 1.62 (1.44, 1.96) years, while participants who improved HLI by the same amount delayed their risk of death by 1.19 (0.65, 2.32) years, compared to those with stable HLI.
CONCLUSIONS CONCLUSIONS
Making healthier lifestyle changes during adulthood was inversely associated with all-cause and cancer mortality and delayed risk of death. Conversely, making unhealthier lifestyle changes was positively associated with mortality and an accelerated risk of death.

Identifiants

pubmed: 38807179
doi: 10.1186/s12916-024-03362-7
pii: 10.1186/s12916-024-03362-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

210

Subventions

Organisme : Institut National du Cancer (INCa) (FR)
ID : AAP SHS-E-SP 2020
Organisme : Institut National du Cancer (INCa) (FR)
ID : SHSESP20-071
Organisme : Institut National du Cancer (INCa) (FR)
ID : IARC-2020-2024

Informations de copyright

© 2024. World Health Organization.

Références

Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49.
doi: 10.1016/S0140-6736(20)30752-2
World Health Organization. The top 10 causes of death. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 2018;138(4):345–55.
doi: 10.1161/CIRCULATIONAHA.117.032047 pubmed: 29712712 pmcid: 6207481
Muller DC, Murphy N, Johansson M, Ferrari P, Tsilidis KK, Boutron-Ruault MC, et al. Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study. BMC Med. 2016;14:87.
doi: 10.1186/s12916-016-0630-6 pubmed: 27296932 pmcid: 4907105
Aleksandrova K, Pischon T, Jenab M, Bueno-de-Mesquita HB, Fedirko V, Norat T, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014;12(1):168.
doi: 10.1186/s12916-014-0168-4 pubmed: 25319089 pmcid: 4192278
Hu P, Zheng M, Huang J, Fan HY, Fan CJ, Ruan HH, et al. Effect of healthy lifestyle index and lifestyle patterns on the risk of mortality: A community-based cohort study. Front Med. 2022;9:920760.
doi: 10.3389/fmed.2022.920760
Chen SLF, Braaten T, Borch KB, Ferrari P, Sandanger TM, Nøst TH. Combined lifestyle behaviors and the incidence of common cancer types in the Norwegian Women and Cancer Study (NOWAC). Clin Epidemiol. 2021;13:721–34.
doi: 10.2147/CLEP.S312864 pubmed: 34429658 pmcid: 8378914
Naudin S, Viallon V, Hashim D, Freisling H, Jenab M, Weiderpass E, et al. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur J Epidemiol. 2020;35(10):975–86.
doi: 10.1007/s10654-019-00559-6 pubmed: 31564045
McKenzie F, Biessy C, Ferrari P, Freisling H, Rinaldi S, Chajès V, et al. Healthy lifestyle and risk of cancer in the European Prospective Investigation into Cancer and Nutrition cohort study. Medicine (Baltimore). 2016;95(16):e2850.
doi: 10.1097/MD.0000000000002850 pubmed: 27100409 pmcid: 4845813
Naudin S, Solans Margalef M, Saberi Hosnijeh F, Nieters A, Kyrø C, Tjønneland A, et al. Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2020;147(6):1649–56.
doi: 10.1002/ijc.32977 pubmed: 32176325
Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18(1):5.
doi: 10.1186/s12916-019-1474-7 pubmed: 31918762 pmcid: 6953215
Molina-Montes E, Ubago-Guisado E, Petrova D, Amiano P, Chirlaque MD, Agudo A, et al. The role of diet, alcohol, BMI, and physical activity in cancer mortality: summary findings of the EPIC study. Nutrients. 2021;13(12):4293.
doi: 10.3390/nu13124293 pubmed: 34959845 pmcid: 8709081
Loef M, Walach H. The combined effects of healthy lifestyle behaviors on all cause mortality: a systematic review and meta-analysis. Prev Med. 2012;55(3):163–70.
doi: 10.1016/j.ypmed.2012.06.017 pubmed: 22735042
Zhang YB, Pan XF, Chen J, Cao A, Zhang YG, Xia L, et al. Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer. 2020;122(7):1085–93.
doi: 10.1038/s41416-020-0741-x pubmed: 32037402 pmcid: 7109112
Botteri E, Peveri G, Berstad P, Bagnardi V, Chen SLF, Sandanger TM, et al. Changes in lifestyle and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Off J Am Coll Gastroenterol ACG. 2023;118(4):702.
doi: 10.14309/ajg.0000000000002065
Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, et al. Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2024; Available from: https://doi.org/10.1007/s10654-023-01059-4
Ding M, Fitzmaurice GM, Arvizu M, Willett WC, Manson JE, Rexrode KM, et al. Associations between patterns of modifiable risk factors in mid-life to late life and longevity: 36 year prospective cohort study. BMJ Med. 2022;1(1):e000098.
doi: 10.1136/bmjmed-2021-000098 pubmed: 36936601 pmcid: 9978682
Ding X, Fang W, Yuan X, Seery S, Wu Y, Chen S, et al. Associations between healthy lifestyle trajectories and the incidence of cardiovascular disease with all-cause mortality: a large, prospective. Chinese cohort study Front Cardiovasc Med. 2021;8:790497.
doi: 10.3389/fcvm.2021.790497 pubmed: 34988131
Hulsegge G, Looman M, Smit HA, Daviglus ML, van der Schouw YT, Verschuren WMM. Lifestyle changes in young adulthood and middle age and risk of cardiovascular disease and all-cause mortality: the Doetinchem Cohort Study. J Am Heart Assoc. 2016;5(1):e002432.
doi: 10.1161/JAHA.115.002432 pubmed: 26764411 pmcid: 4859361
World Health Organization. Social determinants of health. Available from: https://www.who.int/health-topics/social-determinants-of-health
Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. The Lancet. 2017;389(10075):1229–37.
doi: 10.1016/S0140-6736(16)32380-7
Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;14(373):n604.
doi: 10.1136/bmj.n604
Wingard DL. The sex differential in morbidity, mortality, and lifestyle. Annu Rev Public Health. 1984;5:433–58.
doi: 10.1146/annurev.pu.05.050184.002245 pubmed: 6372818
Davis JS, Banfield E, Lee HY, Peng HL, Chang S, Wood AC. Lifestyle behavior patterns and mortality among adults in the NHANES 1988–1994 population: a latent profile analysis. Prev Med. 2019;120:131–9.
doi: 10.1016/j.ypmed.2019.01.012 pubmed: 30660707
Oura P, Rissanen I, Junno JA, Harju T, Paananen M. Lifelong smoking trajectories of Northern Finns are characterized by sociodemographic and lifestyle differences in a 46-year follow-up. Sci Rep. 2020;10(1):16365.
doi: 10.1038/s41598-020-73334-3 pubmed: 33004859 pmcid: 7529914
Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24.
doi: 10.1079/PHN2002394 pubmed: 12639222
van Boeckel PGA, Boshuizen HC, Siersema PD, Vrieling A, Kunst AE, Ye W, et al. No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. 2010;34(6):696–701.
doi: 10.1016/j.canep.2010.08.004 pubmed: 20829145
Cirera L, Huerta JM, Chirlaque MD, Overvad K, Lindström M, Regnér S, et al. Socioeconomic effect of education on pancreatic cancer risk in Western Europe: an update on the EPIC Cohorts Study. Cancer Epidemiol Biomarkers Prev. 2019;28(6):1089–92.
doi: 10.1158/1055-9965.EPI-18-1153 pubmed: 31160392
Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M, Boeing H, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study. BMJ Open. 2014;4(7):e005245–e005245.
doi: 10.1136/bmjopen-2014-005245 pubmed: 24993766 pmcid: 4091394
World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision. World Health Organization; 2004. Available from: https://apps.who.int/iris/handle/10665/42980
Rubin DB, editor. Multiple imputation for nonresponse in surveys. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 1987. (Wiley Series in Probability and Statistics). Available from: http://doi.wiley.com/ https://doi.org/10.1002/9780470316696
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.
doi: 10.1002/sim.4067 pubmed: 21225900
Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology. 1993;4(3):229–36.
doi: 10.1097/00001648-199305000-00006 pubmed: 8512987
Discacciati A, Bellavia A, Orsini N, Greenland S. On the interpretation of risk and rate advancement periods. Int J Epidemiol. 2016;45(1):278–84.
doi: 10.1093/ije/dyv320 pubmed: 26675753
Team RC. R: A language and environment for statistical computing. Vienna, Austria: R: a language and environment for statistical computing; 2019. Available from: https://www.R-project.org/
StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2019.
Ricci C, Wood A, Muller D, Gunter MJ, Agudo A, Boeing H, et al. Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study. BMJ. 2018;361:k934.
doi: 10.1136/bmj.k934 pubmed: 29844013 pmcid: 5972779
Xing Z, Pei J, Huang J, Peng X, Chen P, Hu X, et al. Weight change is associated with increased all-cause mortality and non-cardiac mortality among patients with type 2 diabetes mellitus. Endocrine. 2019;64(1):82–9.
doi: 10.1007/s12020-019-01892-2 pubmed: 30864142
Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, et al. MI and all cause mortality systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156.
doi: 10.1136/bmj.i2156 pubmed: 27146380 pmcid: 4856854
Choi SH, Stommel M, Ling J, Noonan D, Chung J. The impact of smoking and multiple health behaviors on all-cause mortality. Behav Med Wash DC. 2022;48(1):10–7.
doi: 10.1080/08964289.2020.1796570
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–53.
doi: 10.1016/S2213-8587(18)30288-2 pubmed: 30389323 pmcid: 6249991
Tian F, Shen Q, Hu Y, Ye W, Valdimarsdóttir UA, Song H, et al. Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: a population-based and sibling-controlled cohort study. Lancet Reg Health Eur. 2022;18:100402.
doi: 10.1016/j.lanepe.2022.100402 pubmed: 35663363 pmcid: 9160321
Åkerstedt T, Ghilotti F, Grotta A, Zhao H, Adami HO, Trolle-Lagerros Y, et al. Sleep duration and mortality - does weekend sleep matter? J Sleep Res. 2019;28(1):e12712.
doi: 10.1111/jsr.12712 pubmed: 29790200
Gallo V, Mackenbach JP, Ezzati M, Menvielle G, Kunst AE, Rohrmann S, et al. Social inequalities and mortality in Europe – results from a large multi-national cohort. Behrens T, editor. PloS One. 2012;7(7):e39013.
Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. Mediating role of lifestyle behaviors in the association between education and cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2023;32(1):132–40.
doi: 10.1158/1055-9965.EPI-22-0777

Auteurs

Komodo Matta (K)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Vivian Viallon (V)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Edoardo Botteri (E)

Cancer Registry of Norway (Kreftregisteret), Oslo, Norway.

Giulia Peveri (G)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Christina Dahm (C)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anne Østergaard Nannsen (AØ)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anja Olsen (A)

Department of Public Health, Aarhus University, Aarhus, Denmark.
Danish Cancer Society Research Center, Copenhagen, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Alexis Elbaz (A)

Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.

Fanny Artaud (F)

Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.

Chloé Marques (C)

Inserm, Université Paris Saclay, Institut Gustave Roussy, Team Exposome, Heredity, Cancer and Health, CESP UMR 1018, 94807, Villejuif, France.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Erand Llanaj (E)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Giovanna Masala (G)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Salvatore Panico (S)

Dipartimento di Medicina Clinica, Federico II University, Naples, Italy.

Rosario Tumino (R)

Hyblean Association for Epidemiological Research, AIRE ONLUS, Ragusa, Italy.

Fulvio Ricceri (F)

Centre for Biostatistics, Epidemiology, Department of Clinical and Biological Sciences, and Public Health (C-BEPH), University of Turin, Turin, Italy.

Jeroen W G Derksen (JWG)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Therese Haugdahl Nøst (TH)

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Torkjel M Sandanger (TM)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Kristin Benjaminsen Borch (KB)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Carlota Castro-Espin (C)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Maria-José Sánchez (MJ)

Escuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, 18071, Granada, Spain.

Amaia Aizpurua Atxega (AA)

Sub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, San Sebastian, Spain.
Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain.

Lluís Cirera (L)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Department of Health and Social Sciences, University of Murcia, Murcia, Spain.

Marcela Guevara (M)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Instituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), 31008, Pamplona, Spain.

Jonas Manjer (J)

Department of Surgery, Skåne University Hospital Malmö, Lund University, Malmö, Sweden.

Sandar Tin Tin (S)

Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, England.

Alicia Heath (A)

School of Public Health, Imperial College London, London, UK.

Mathilde Touvier (M)

L'Institut national de la santé et de la recherche médicale (Inserm), Paris, France.

Marcel Goldberg (M)

Université Paris Descartes, Paris, France.

Elisabete Weiderpass (E)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Marc J Gunter (MJ)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.
School of Public Health, Imperial College London, London, UK.

Heinz Freisling (H)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Elio Riboli (E)

School of Public Health, Imperial College London, London, UK.

Pietro Ferrari (P)

International Agency for Research on Cancer (IARC-WHO), Lyon, France. ferrarip@iarc.who.int.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH